1. Home
  2. ASPI vs PRAX Comparison

ASPI vs PRAX Comparison

Compare ASPI & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPI
  • PRAX
  • Stock Information
  • Founded
  • ASPI 2021
  • PRAX 2015
  • Country
  • ASPI United States
  • PRAX United States
  • Employees
  • ASPI N/A
  • PRAX N/A
  • Industry
  • ASPI Major Chemicals
  • PRAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASPI Industrials
  • PRAX Health Care
  • Exchange
  • ASPI Nasdaq
  • PRAX Nasdaq
  • Market Cap
  • ASPI 653.4M
  • PRAX 599.7M
  • IPO Year
  • ASPI 2022
  • PRAX 2020
  • Fundamental
  • Price
  • ASPI $6.84
  • PRAX $51.18
  • Analyst Decision
  • ASPI Strong Buy
  • PRAX Strong Buy
  • Analyst Count
  • ASPI 2
  • PRAX 10
  • Target Price
  • ASPI $7.75
  • PRAX $101.00
  • AVG Volume (30 Days)
  • ASPI 3.6M
  • PRAX 251.4K
  • Earning Date
  • ASPI 08-18-2025
  • PRAX 08-12-2025
  • Dividend Yield
  • ASPI N/A
  • PRAX N/A
  • EPS Growth
  • ASPI N/A
  • PRAX N/A
  • EPS
  • ASPI N/A
  • PRAX N/A
  • Revenue
  • ASPI $4,405,477.00
  • PRAX $8,122,000.00
  • Revenue This Year
  • ASPI $512.64
  • PRAX N/A
  • Revenue Next Year
  • ASPI $181.15
  • PRAX $6,358.50
  • P/E Ratio
  • ASPI N/A
  • PRAX N/A
  • Revenue Growth
  • ASPI 245.97
  • PRAX 270.02
  • 52 Week Low
  • ASPI $1.86
  • PRAX $26.70
  • 52 Week High
  • ASPI $10.08
  • PRAX $91.83
  • Technical
  • Relative Strength Index (RSI)
  • ASPI 45.07
  • PRAX 69.52
  • Support Level
  • ASPI $6.59
  • PRAX $45.70
  • Resistance Level
  • ASPI $7.24
  • PRAX $48.00
  • Average True Range (ATR)
  • ASPI 0.53
  • PRAX 2.23
  • MACD
  • ASPI -0.12
  • PRAX 0.35
  • Stochastic Oscillator
  • ASPI 25.00
  • PRAX 95.91

About ASPI ASP Isotopes Inc.

ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: